Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Andrographis and Boesenbergia Extracts in Asymptomatic COVID-19
NCT05019326Phase 3Unknown
- Sponsor
- Mahidol University
- Start
- Aug 2021
- Primary completion
- May 2022
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 3 trial of andrographis paniculata, Boesenbergia rotunda in coronavirus disease 2019 (COVID-19), sponsored by Mahidol University. Status: unknown.
02
Drugs
andrographis paniculataBoesenbergia rotunda
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05019326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05019326.